Wealth Quarterback’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
AIM
CWP
DADC
WG
Wealth Quarterback's PFE Position: Q2 2026 in Review
Wealth Quarterback sold out of Pfizer (PFE) in Q2 2026, closing a stake of 7,642 shares — an estimated $215K sold.
Wealth Quarterback first reported a position in PFE in Q4 2019 and held it in 18 quarters. The position peaked at $538K in Q2 2022. 916 funds tracked by Wall St. Rank hold PFE as of Q2 2026.
- Wealth Quarterback reported no remaining Pfizer position as of Q2 2026 after selling out during the quarter.
- Wealth Quarterback sold 7,642 Pfizer shares in Q2 2026, an estimated $215K.
- Wealth Quarterback first reported a position in Pfizer in Q4 2019 and held it in 18 quarters.
- Wealth Quarterback's Pfizer position peaked at $538K in Q2 2022.
- 916 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.
Based on Wealth Quarterback's 13F filing for Q2 2026, filed 27 Jul 2026.